Refresh

Wockhardt Ltd.

Price on BSE   04 Sep,15:50 LIVE
2,086.75
+135.70
(+6.96%)

© 2026 Rediff.com
  • Volume :
  • 428,232.00
  • Prev Close :
  • 1,951.05
  • Day's H/L (Rs.) :
  • 2,107.95 - 1,975.25
  • 52wk H/L (Rs.) :
  • 2,420.00 - 1,086.80
  • Mkt Cap (Rs. Cr) :
  • 33,909.69
Price on NSE   04 Sep,15:58 LIVE
2,088.70
+138.10
(+7.08%)

© 2026 Rediff.com
  • Volume :
  • 3,557,625.00
  • Prev Close :
  • 1,950.60
  • Day's H/L (Rs.) :
  • 2,108.50 - 1,976.10
  • 52wk H/L (Rs.) :
  • 2,422.30 - 1,086.70
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Can Headaches Be A Sign Of Brain Tumour?
Rediff.com   08 Jun 2026
Report Card - Wockhardt Ltd.
PE Ratios
106.67
EPS (Rs.)
19.56
Sales (Rs. Cr)
561.00
Face Value (Rs.)
5
Net Profit Margin(%)
18.22
Last Bonus
1:2
Last Dividend(%)
200
Return on Average Equity
10.27

News for Wockhardt Ltd.

Wockhardt Ltd Reports Rs 107 Cr Q1 Profit After Tax
Wockhardt Ltd announced a consolidated profit after tax of Rs 107 crore for Q1 ended June 30, driven by strong revenue growth. Company turned profitable from a loss.
Aug 10, 2026 15:57
Wockhardt UTI Drug Zaynich Approved in India
Wockhardt receives CDSCO approval to market Zaynich, a new antibiotic for complicated UTIs, including kidney infections, in India.
May 28, 2026 16:27
Wockhardt Zaynich Antibiotic Gets CDSCO Approval
Wockhardt receives CDSCO approval for Zaynich (Zidebactam/Cefepime) antibiotic for complicated urinary tract infections in India.
May 28, 2026 11:30
Wockhardt Posts Rs 164 Cr Profit in Jan-Mar Quarter
Wockhardt Ltd reports Rs 164 crore net profit in Q4 ended March 31, 2026, against a loss last year. Revenue rises to Rs 965 crore.
May 04, 2026 16:21
Wockhardt Q3 Profit Jumps 3x to Rs 61 Cr
Wockhardt's Q3 profit after tax surged threefold to Rs 61 crore. Revenue rose to Rs 888 crore. Upcoming insulin analogs launch is a key opportunity.
Feb 10, 2026 17:38

More News for Wockhardt Ltd. »

About Wockhardt Ltd.

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia

News for Pharmaceuticals

CM Fadnavis Lays Stone for Bajaj Finserv AI Campus in Pune
Maharashtra CM Fadnavis laid the foundation for Bajaj Finserv's AI & IoT-powered 'sentient' campus in Pune, set to be India's largest financial services office.
Sep 04, 2026 22:31
NFRA Forms Advisory Panel on Audit Quality & Technology
NFRA establishes a 9-member advisory committee, including ex-RBI Dy Governor Shyamala Gopinath, to enhance audit quality, assurance, and technology in financial reporting.
Sep 04, 2026 21:46
Pranav Constructions Raises ₹84 Cr from Anchor Investors
Pranav Constructions secured ₹84.24 crore from anchor investors like Goldman Sachs ahead of its ₹351 Cr IPO opening Sept 7-9. Price band ₹118-124.
Sep 04, 2026 21:42
RBI Penalizes 5 Entities: CIBIL, CRIF, Equifax & More
RBI imposes monetary penalties on TransUnion CIBIL, CRIF, Equifax, Sammaan Finserve, and Hinduja Leyland Finance for regulatory non-compliance.
Sep 04, 2026 21:08
RBI to Hold Rs 7 Lakh Cr 30-Day VRRR Auction on Sep 7
The RBI will conduct a Rs 7 lakh crore 30-day Variable Rate Reverse Repo (VRRR) auction on Sep 7 to absorb excess liquidity from the banking system.
Sep 04, 2026 20:47

More News »

Top News

CM Fadnavis Lays Stone for Bajaj Finserv AI Campus in Pune
Maharashtra CM Fadnavis laid the foundation for Bajaj Finserv's AI & IoT-powered 'sentient' campus in Pune, set to be India's largest financial services office.
Sep 04, 2026 22:31
NFRA Forms Advisory Panel on Audit Quality & Technology
NFRA establishes a 9-member advisory committee, including ex-RBI Dy Governor Shyamala Gopinath, to enhance audit quality, assurance, and technology in financial reporting.
Sep 04, 2026 21:46
Pranav Constructions Raises ₹84 Cr from Anchor Investors
Pranav Constructions secured ₹84.24 crore from anchor investors like Goldman Sachs ahead of its ₹351 Cr IPO opening Sept 7-9. Price band ₹118-124.
Sep 04, 2026 21:42
NTPC Korba Plant Trips Due to Electrical Fault During PGCIL Test
All 7 units of NTPC Korba power plant in Chhattisgarh tripped due to an electrical fault during PGCIL breaker testing. Restoration is underway.
Sep 04, 2026 21:25
RBI Penalizes 5 Entities: CIBIL, CRIF, Equifax & More
RBI imposes monetary penalties on TransUnion CIBIL, CRIF, Equifax, Sammaan Finserve, and Hinduja Leyland Finance for regulatory non-compliance.
Sep 04, 2026 21:08

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com